Enzyme, the on-chain asset management protocol, acquires a majority stake in MYSO Finance to expand its customized options business.

TechFlow news, September 4th, the on-chain asset management protocol Enzyme Finance announced that it is acquiring a majority stake in the $DeFi protocol MYSO Finance. This acquisition will enable Enzyme to offer its clients customized covered call option services, further expanding its business scope.

MYSO Finance is a protocol aimed at integrating $DeFi and traditional financial concepts. Its MYSO v2 version implements a trust-minimized lending protocol on the EVM, supporting zero-liquidation lending (ZLL) functionality. This innovation allows users to engage in crypto-collateralized lending without facing liquidation risks.

Enzyme, as a user-friendly $DeFi asset management system, provides convenient access services for funds, investment clubs, DAO treasuries, and corporations. By integrating various protocols and simplifying the asset management experience for users, Enzyme is committed to reducing the complexity of interacting with $DeFi, offering a more seamless operational experience for users.